Maria-Anna Chrysovergi

Also affiliated with Massachusetts General Hospital, Dana-Farber Cancer Institute

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Sanglifehrin A mitigates multiorgan fibrosis by targeting the collagen chaperone cyclophilin B”.

Sanglifehrin A mitigates multiorgan fibrosis by targeting the collagen chaperone cyclophilin B

JCI Insight(2024)10.1172/jci.insight.171162

N/A

0.330DataRank · unranked

8 citations

Maria-Anna Chrysovergi, Hongwei Han, Farah Kabir, Rachael T. Lister, Chia‐Fu Chang +9 more

Sanglifehrin A mitigates multi-organ fibrosis in vivo by inducing secretion of the collagen chaperone cyclophilin B

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.03.09.531890

N/A

0.243DataRank · unranked

3 citations

Maria-Anna Chrysovergi, Hongwei Han, Farah Kabir, Rachael T. Lister, Chia‐Fu Chang +4 more

α TAT1 defines a microtubule mechanosensing axis that drives fibroblast durotaxis and fibrosis across organs

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.10.20.682962

N/A

0DataRank · unranked

0 citations

Tamanna Islam, Maria-Anna Chrysovergi, Paula E. Grasberger, Vera Auernheimer, Taslim A. Al‐Hilal +3 more